Perspectivas del mercado y visión del analista:
El tratamiento de las alergias oculares incluye medicamentos de venta libre y recetados utilizados para aliviar síntomas como enrojecimiento, picazón, lagrimeo e hinchazón de los ojos. Algunos de los productos comúnmente utilizados incluyen gotas para los ojos antihistamínicos, estabilizadores de mastocitos y terapias combinadas. Los tipos principales de alergia ocular son la conjuntivitis alérgica estacional o perenne, la queratoconjuntivitis vernal, la queratoconjuntivitis atópica y la conjuntivitis alérgica de contacto. La creciente prevalencia de alergias oculares en todo el mundo y la disponibilidad de soluciones de venta libre favorecen el crecimiento del mercado de tratamiento de alergias oculares.
Impulsores de crecimiento:
Las alergias oculares, también conocidas como conjuntivitis alérgica, son provocadas por polen, polvo, animales y moho. Los crecientes niveles de contaminación del aire han contribuido a la creciente incidencia de alergias oculares. Además, los cambios en el estilo de vida y los hábitos alimentarios, el aumento de la exposición a los alérgenos, el aumento del tiempo frente a las pantallas, que provoca fatiga ocular y el aumento de la susceptibilidad a las molestias oculares, han contribuido a un aumento sustancial de las reacciones alérgicas oculares entre la población mundial.
Según un En un estudio titulado “Una mirada contemporánea a la conjuntivitis alérgica”, publicado en 2020, la enfermedad ocular alérgica es un problema común entre la población norteamericana. Afecta a casi el 40% de la población y este número está aumentando. La mitad de la población estadounidense que sufre síntomas de alergia ocular necesita medicación para aliviarlos. Aun así, sólo una fracción de ellos usa medicamentos recetados, lo que hace que el desarrollo de estos nuevos tratamientos sea especialmente atractivo.
El tratamiento de las alergias oculares incluye productos y soluciones que se utilizan para tratar y controlar las alergias que afectan a los ojos. El tratamiento incluye medicamentos de venta libre y recetados que se usan para aliviar síntomas como enrojecimiento, picazón, lagrimeo e hinchazón de los ojos. Algunos productos de uso común incluyen gotas para los ojos antihistamínicos, estabilizadores de mastocitos y medicamentos antiinflamatorios no esteroides. El crecimiento del número de personas que padecen alergias oculares genera una mayor demanda de opciones de tratamiento. Esto aumentó la demanda de opciones de tratamiento, impulsando así el crecimiento del mercado de tratamiento de alergias oculares.
Las tendencias del mercado de tratamiento de alergias oculares incluyen el desarrollo de terapias combinadas que favorecerán el crecimiento del mercado en el futuro.
Perspectivas estratégicas< br>Segmentación y alcance del informe:
El análisis de mercado de tratamiento de alergia ocular se ha realizado considerando los siguientes segmentos: tratamiento, indicación, canal de distribución y geografía. Según el tratamiento, el mercado se clasifica en medicamentos, vacunas contra las alergias y gotas para los ojos. En términos de indicación, el mercado se clasifica en conjuntivitis alérgica estacional y perenne, queratoconjuntivitis primaveral, queratoconjuntivitis atópica, conjuntivitis alérgica de contacto y conjuntivitis papilar gigante. En términos de canales de distribución, el mercado está segmentado en farmacias hospitalarias, farmacias en línea y droguerías. El alcance del informe del mercado de tratamiento de alergias oculares cubre América del Norte (EE. UU., Canadá y México), Europa (Francia, Alemania, el Reino Unido, España, Italia y el resto de Europa), Asia Pacífico (China, Japón, India, Corea del Sur, Australia y el resto de Asia Pacífico), Medio Oriente y África (Arabia Saudita, Emiratos Árabes Unidos, Sudáfrica y el resto de Medio Oriente y África) y América del Sur y Central (Brasil, Argentina y el resto de América del Sur y Central).
Análisis segmentario:
El mercado de tratamiento de alergia ocular, por tratamiento. , se clasifica en medicamentos, vacunas contra las alergias y gotas para los ojos. El segmento de gotas para los ojos tuvo una participación de mercado significativa en 2022. Se prevé que registre la CAGR más alta del mercado durante 2022-2030. Según la indicación, el mercado se clasifica en conjuntivitis alérgica estacional y perenne, queratoconjuntivitis vernal, atópica. queratoconjuntivitis, conjuntivitis alérgica de contacto y conjuntivitis papilar gigante. El segmento de conjuntivitis alérgica estacional y perenne tuvo una participación de mercado significativa en el tratamiento de alergias oculares en 2022 y se estima que registrará la CAGR más alta durante 2022-2030. Según los canales de distribución, el mercado se segmenta en farmacias hospitalarias, farmacias en línea y Farmacias. El segmento de farmacias hospitalarias tuvo una importante participación de mercado de tratamiento de alergias oculares en 2022. Además, se espera que el segmento de farmacias en línea registre la CAGR más alta durante 2022-2030.
Mercado de tratamiento de alergias oculares, por tratamiento: 2022 y 2030
Análisis regional:
Según la geografía, el informe de mercado de Tratamiento de alergias oculares se divide principalmente en América del Norte, Europa, Asia Pacífico, América del Sur y Central, y Medio Oriente y África. En 2022, América del Norte captó una parte importante del mercado. En 2022, Estados Unidos tenía la mayor participación del mercado en la región. El crecimiento del mercado en América del Norte se atribuye a la disponibilidad de infraestructura sanitaria moderna, la fuerte presencia de actores clave del mercado, el creciente número de alergias oculares y enfermedades del ojo seco y la introducción de medicamentos de vanguardia. Según Baptist Health, casi 50 millones de estadounidenses padecen algún tipo de alergia estacional. Aproximadamente el 30% de todos los adultos y el 40% de todos los niños experimentan reacciones alérgicas que afectan los ojos, los párpados y los conductos lagrimales.
Un ojo seco puede provocar alergias oculares, que en consecuencia provocarán la enfermedad del ojo seco. La enfermedad del ojo seco es un trastorno común, aunque infradiagnosticado, en los EE. UU. Según los datos de la Encuesta Nacional de Salud y Bienestar publicada en 2020, al 6,8% de la población adulta de EE. UU. se le diagnosticó ojo seco. Según el artículo 'Factores de riesgo de daño en la superficie ocular en pacientes mexicanos con enfermedad del ojo seco: un estudio poblacional', publicado en 2019, casi el 58% de las personas se quejaron de ojo seco.
Las empresas farmacéuticas están mejorando el acceso a tratamientos especializados, como colirios para aliviar las alergias, para ampliar su alcance en la región. Desde marzo de 2022, LASTACAFT (solución oftálmica de alcaftadina al 0,25%) de Allergan estuvo disponible sin receta para los estadounidenses con alergias oculares. Tras la reciente aprobación de la Administración de Alimentos y Medicamentos de EE. UU. de un cambio completo de prescripción a venta libre, la formulación original patentada y potente de LASTACAFT se puede encontrar en línea y en tiendas minoristas donde se venden gotas para los ojos de venta libre. Por lo tanto, los factores mencionados anteriormente impulsan el mercado de tratamiento de alergias oculares en la región.
Desarrollos de la industria y oportunidades futuras:
A continuación se enumeran algunas iniciativas adoptadas por los actores del mercado que operan en el mercado mundial de tratamientos de alergias oculares:
•En septiembre de 2020, Dr Reddy's Laboratories lanzó una gota para las alergias oculares de venta libre, la solución oftálmica de clorhidrato de olopatadina, en el mercado estadounidense. La solución está indicada para aliviar temporalmente la picazón en los ojos debido al polen, el pasto, el pelo de animales y la caspa. En febrero de 2020, Alcon recibió la aprobación de la Administración de Alimentos y Medicamentos para el alivio de Pataday una vez al día y el alivio de Pataday dos veces al día para el exceso de venta sin receta en EE.UU. La marca Pataday presenta el ingrediente número uno para aliviar la picazón de las alergias oculares recetado por un médico e incluye la primera gota para aliviar la picazón de las alergias que se toma una vez al día y está disponible sin receta. Panorama competitivo y empresas clave:
El pronóstico del mercado de tratamiento de las alergias oculares puede ayudar a las partes interesadas a planificar sus estrategias de crecimiento. Bausch + Lomb, Alcon, AbbVie, Johnson & Johnson, Akorn Inc., Nicox, Santen Pharmaceutical Co. Ltd, Teva Pharmaceutical Industries Ltd, Novartis AG y Sun Pharmaceutical Industries Ltd. se encuentran entre los actores destacados del mercado. Estas empresas se centran en introducir nuevos productos de alta tecnología, avances en productos existentes y expansiones geográficas para satisfacer la creciente demanda de los consumidores en todo el mundo.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Eye allergy treatment includes products and solutions that are used to treat and manage allergies affecting the eyes. Treatment includes over-the-counter medications and prescription drugs that are used to alleviate symptoms such as redness, itching, tearing, and swelling of the eyes. Some of the commonly used products include antihistamine eye drops, mast cell stabilizers, and combination therapies.
The eye allergy treatment market majorly consists of the players, including Bausch + Lomb, Alcon, AbbVie, Johnson & Johnson, Akorn Inc., Nicox, Santen Pharmaceutical Co. Ltd, Teva Pharmaceutical Industries Ltd, Novartis AG, and Sun Pharmaceutical Industries Ltd.
The factors driving the growth of the eye allergy treatment market include the increasing prevalence of eye allergies worldwide and a significant number of switches from prescription to over-the-counter drugs. However, a lack of awareness of ocular allergies hampers the growth of the eye allergy treatment market.
The global eye allergy treatment market is segmented based on treatment, indication, and distribution channel. The eye allergy treatment market, by treatment, is categorized into medication, allergy shots, and eye drops. The eye drops segment held a significant market share in 2022 and is anticipated to record the highest CAGR in the market during 2022–2030.
The eye allergy treatment market was valued at US$ 3.59 billion in 2022.
The eye allergy treatment market is expected to be valued at US$ 5.69 billion in 2030.
The List of Companies - Eye Allergy Treatment Market
- Bausch + Lomb
- Alcon
- AbbVie
- Johnson & Johnson
- Akorn Inc.
- Nicox
- Santen Pharmaceutical Co. Ltd
- Teva Pharmaceutical Industries Ltd
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Feb 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Feb 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Feb 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)